Baidu
map

JACC:女性非ST段抬高型心梗患者不良事件发生率低于男性

2019-12-12 不详 MedSci原创

非ST段抬高型急性冠脉综合征(NSTEACS)女性患者的不良事件发生率是否高于男性仍不确定,本研究的目的旨在评估NSTEACS患者预后的性别差异。本研究共纳入分析了68730名NSTEACS患者,其中19827名(29%)为女性,相比于男性患者,女性年龄更大,且发生高血压、糖尿病、心衰和肾功能不全的风险更大。在考虑混杂因素之前,女性和男性患者的主要心血管不良事件(MACE)发生率无明显差异([HR

非ST段抬高型急性冠脉综合征(NSTEACS)女性患者的不良事件发生率是否高于男性仍不确定,本研究的目的旨在评估NSTEACS患者预后的性别差异。

本研究共纳入分析了68730名NSTEACS患者,其中19827名(29%)为女性,相比于男性患者,女性年龄更大,且发生高血压糖尿病心衰和肾功能不全的风险更大。在考虑混杂因素之前,女性和男性患者的主要心血管不良事件(MACE)发生率无明显差异([HR]: 1.04; 95% [CI]: 0.99-1.09; p = 0.16),但女性的全因死亡风险更高(HR: 1.12; 95% CI: 1.01-1.24; p = 0.03)。另外,经基线基础特征因素调整分析后发现,MACE和全因死亡风险在女性患者中明显更低。

研究结果显示,经心血管危险因素调整分析后,女性NSTEACS患者的不良预后发生率低于男性。然而,女性患者尚未得到充分的治疗。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2066048, encodeId=28142066048e5, content=<a href='/topic/show?id=fec79922910' target=_blank style='color:#2F92EE;'>#非ST段抬高型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99229, encryptionId=fec79922910, topicName=非ST段抬高型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Sep 13 09:38:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826564, encodeId=e639182656416, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Sep 21 16:38:00 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819113, encodeId=669f1819113d3, content=<a href='/topic/show?id=de2d99226e2' target=_blank style='color:#2F92EE;'>#非ST段#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99226, encryptionId=de2d99226e2, topicName=非ST段)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Tue Sep 22 01:38:00 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854612, encodeId=2137185461238, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Aug 14 07:38:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811983, encodeId=e8c48119832b, content=女性非ST段抬高型<a href='/topic/show?id=0cb1510519b' target=_blank style='color:#2F92EE;'>#心梗#</a>患者<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>发生率低于男性,这几乎是必然的。女性的<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的, beContent=null, objectType=article, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51051, encryptionId=0cb1510519b, topicName=心梗), TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Aug 22 09:44:34 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926998, encodeId=ccf3192699811, content=<a href='/topic/show?id=be549922826' target=_blank style='color:#2F92EE;'>#非ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99228, encryptionId=be549922826, topicName=非ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ed3112, createdName=echonoir, createdTime=Wed Mar 25 19:38:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049508, encodeId=e58120495087a, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Wed Jan 15 06:38:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024062, encodeId=c50e20240620a, content=<a href='/topic/show?id=0ee11686460' target=_blank style='color:#2F92EE;'>#ST段抬高型心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16864, encryptionId=0ee11686460, topicName=ST段抬高型心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Mon Jun 29 09:38:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326439, encodeId=2e4113264396c, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423097, encodeId=3c73142309eb9, content=<a href='/topic/show?id=936c16863b5' target=_blank style='color:#2F92EE;'>#ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16863, encryptionId=936c16863b5, topicName=ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d33758978, createdName=gdsun, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2066048, encodeId=28142066048e5, content=<a href='/topic/show?id=fec79922910' target=_blank style='color:#2F92EE;'>#非ST段抬高型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99229, encryptionId=fec79922910, topicName=非ST段抬高型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Sep 13 09:38:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826564, encodeId=e639182656416, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Sep 21 16:38:00 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819113, encodeId=669f1819113d3, content=<a href='/topic/show?id=de2d99226e2' target=_blank style='color:#2F92EE;'>#非ST段#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99226, encryptionId=de2d99226e2, topicName=非ST段)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Tue Sep 22 01:38:00 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854612, encodeId=2137185461238, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Aug 14 07:38:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811983, encodeId=e8c48119832b, content=女性非ST段抬高型<a href='/topic/show?id=0cb1510519b' target=_blank style='color:#2F92EE;'>#心梗#</a>患者<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>发生率低于男性,这几乎是必然的。女性的<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的, beContent=null, objectType=article, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51051, encryptionId=0cb1510519b, topicName=心梗), TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Aug 22 09:44:34 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926998, encodeId=ccf3192699811, content=<a href='/topic/show?id=be549922826' target=_blank style='color:#2F92EE;'>#非ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99228, encryptionId=be549922826, topicName=非ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ed3112, createdName=echonoir, createdTime=Wed Mar 25 19:38:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049508, encodeId=e58120495087a, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Wed Jan 15 06:38:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024062, encodeId=c50e20240620a, content=<a href='/topic/show?id=0ee11686460' target=_blank style='color:#2F92EE;'>#ST段抬高型心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16864, encryptionId=0ee11686460, topicName=ST段抬高型心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Mon Jun 29 09:38:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326439, encodeId=2e4113264396c, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423097, encodeId=3c73142309eb9, content=<a href='/topic/show?id=936c16863b5' target=_blank style='color:#2F92EE;'>#ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16863, encryptionId=936c16863b5, topicName=ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d33758978, createdName=gdsun, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2066048, encodeId=28142066048e5, content=<a href='/topic/show?id=fec79922910' target=_blank style='color:#2F92EE;'>#非ST段抬高型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99229, encryptionId=fec79922910, topicName=非ST段抬高型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Sep 13 09:38:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826564, encodeId=e639182656416, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Sep 21 16:38:00 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819113, encodeId=669f1819113d3, content=<a href='/topic/show?id=de2d99226e2' target=_blank style='color:#2F92EE;'>#非ST段#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99226, encryptionId=de2d99226e2, topicName=非ST段)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Tue Sep 22 01:38:00 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854612, encodeId=2137185461238, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Aug 14 07:38:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811983, encodeId=e8c48119832b, content=女性非ST段抬高型<a href='/topic/show?id=0cb1510519b' target=_blank style='color:#2F92EE;'>#心梗#</a>患者<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>发生率低于男性,这几乎是必然的。女性的<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的, beContent=null, objectType=article, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51051, encryptionId=0cb1510519b, topicName=心梗), TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Aug 22 09:44:34 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926998, encodeId=ccf3192699811, content=<a href='/topic/show?id=be549922826' target=_blank style='color:#2F92EE;'>#非ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99228, encryptionId=be549922826, topicName=非ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ed3112, createdName=echonoir, createdTime=Wed Mar 25 19:38:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049508, encodeId=e58120495087a, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Wed Jan 15 06:38:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024062, encodeId=c50e20240620a, content=<a href='/topic/show?id=0ee11686460' target=_blank style='color:#2F92EE;'>#ST段抬高型心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16864, encryptionId=0ee11686460, topicName=ST段抬高型心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Mon Jun 29 09:38:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326439, encodeId=2e4113264396c, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423097, encodeId=3c73142309eb9, content=<a href='/topic/show?id=936c16863b5' target=_blank style='color:#2F92EE;'>#ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16863, encryptionId=936c16863b5, topicName=ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d33758978, createdName=gdsun, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
    2020-09-22 lxg951
  4. [GetPortalCommentsPageByObjectIdResponse(id=2066048, encodeId=28142066048e5, content=<a href='/topic/show?id=fec79922910' target=_blank style='color:#2F92EE;'>#非ST段抬高型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99229, encryptionId=fec79922910, topicName=非ST段抬高型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Sep 13 09:38:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826564, encodeId=e639182656416, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Sep 21 16:38:00 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819113, encodeId=669f1819113d3, content=<a href='/topic/show?id=de2d99226e2' target=_blank style='color:#2F92EE;'>#非ST段#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99226, encryptionId=de2d99226e2, topicName=非ST段)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Tue Sep 22 01:38:00 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854612, encodeId=2137185461238, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Aug 14 07:38:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811983, encodeId=e8c48119832b, content=女性非ST段抬高型<a href='/topic/show?id=0cb1510519b' target=_blank style='color:#2F92EE;'>#心梗#</a>患者<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>发生率低于男性,这几乎是必然的。女性的<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的, beContent=null, objectType=article, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51051, encryptionId=0cb1510519b, topicName=心梗), TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Aug 22 09:44:34 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926998, encodeId=ccf3192699811, content=<a href='/topic/show?id=be549922826' target=_blank style='color:#2F92EE;'>#非ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99228, encryptionId=be549922826, topicName=非ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ed3112, createdName=echonoir, createdTime=Wed Mar 25 19:38:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049508, encodeId=e58120495087a, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Wed Jan 15 06:38:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024062, encodeId=c50e20240620a, content=<a href='/topic/show?id=0ee11686460' target=_blank style='color:#2F92EE;'>#ST段抬高型心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16864, encryptionId=0ee11686460, topicName=ST段抬高型心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Mon Jun 29 09:38:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326439, encodeId=2e4113264396c, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423097, encodeId=3c73142309eb9, content=<a href='/topic/show?id=936c16863b5' target=_blank style='color:#2F92EE;'>#ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16863, encryptionId=936c16863b5, topicName=ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d33758978, createdName=gdsun, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
    2020-08-14 hbwxf
  5. [GetPortalCommentsPageByObjectIdResponse(id=2066048, encodeId=28142066048e5, content=<a href='/topic/show?id=fec79922910' target=_blank style='color:#2F92EE;'>#非ST段抬高型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99229, encryptionId=fec79922910, topicName=非ST段抬高型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Sep 13 09:38:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826564, encodeId=e639182656416, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Sep 21 16:38:00 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819113, encodeId=669f1819113d3, content=<a href='/topic/show?id=de2d99226e2' target=_blank style='color:#2F92EE;'>#非ST段#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99226, encryptionId=de2d99226e2, topicName=非ST段)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Tue Sep 22 01:38:00 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854612, encodeId=2137185461238, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Aug 14 07:38:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811983, encodeId=e8c48119832b, content=女性非ST段抬高型<a href='/topic/show?id=0cb1510519b' target=_blank style='color:#2F92EE;'>#心梗#</a>患者<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>发生率低于男性,这几乎是必然的。女性的<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的, beContent=null, objectType=article, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51051, encryptionId=0cb1510519b, topicName=心梗), TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Aug 22 09:44:34 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926998, encodeId=ccf3192699811, content=<a href='/topic/show?id=be549922826' target=_blank style='color:#2F92EE;'>#非ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99228, encryptionId=be549922826, topicName=非ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ed3112, createdName=echonoir, createdTime=Wed Mar 25 19:38:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049508, encodeId=e58120495087a, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Wed Jan 15 06:38:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024062, encodeId=c50e20240620a, content=<a href='/topic/show?id=0ee11686460' target=_blank style='color:#2F92EE;'>#ST段抬高型心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16864, encryptionId=0ee11686460, topicName=ST段抬高型心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Mon Jun 29 09:38:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326439, encodeId=2e4113264396c, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423097, encodeId=3c73142309eb9, content=<a href='/topic/show?id=936c16863b5' target=_blank style='color:#2F92EE;'>#ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16863, encryptionId=936c16863b5, topicName=ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d33758978, createdName=gdsun, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
    2020-08-22 lovetcm

    女性非ST段抬高型#心梗#患者#不良事件#发生率低于男性,这几乎是必然的。女性的#雌激素#保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2066048, encodeId=28142066048e5, content=<a href='/topic/show?id=fec79922910' target=_blank style='color:#2F92EE;'>#非ST段抬高型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99229, encryptionId=fec79922910, topicName=非ST段抬高型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Sep 13 09:38:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826564, encodeId=e639182656416, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Sep 21 16:38:00 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819113, encodeId=669f1819113d3, content=<a href='/topic/show?id=de2d99226e2' target=_blank style='color:#2F92EE;'>#非ST段#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99226, encryptionId=de2d99226e2, topicName=非ST段)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Tue Sep 22 01:38:00 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854612, encodeId=2137185461238, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Aug 14 07:38:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811983, encodeId=e8c48119832b, content=女性非ST段抬高型<a href='/topic/show?id=0cb1510519b' target=_blank style='color:#2F92EE;'>#心梗#</a>患者<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>发生率低于男性,这几乎是必然的。女性的<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的, beContent=null, objectType=article, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51051, encryptionId=0cb1510519b, topicName=心梗), TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Aug 22 09:44:34 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926998, encodeId=ccf3192699811, content=<a href='/topic/show?id=be549922826' target=_blank style='color:#2F92EE;'>#非ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99228, encryptionId=be549922826, topicName=非ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ed3112, createdName=echonoir, createdTime=Wed Mar 25 19:38:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049508, encodeId=e58120495087a, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Wed Jan 15 06:38:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024062, encodeId=c50e20240620a, content=<a href='/topic/show?id=0ee11686460' target=_blank style='color:#2F92EE;'>#ST段抬高型心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16864, encryptionId=0ee11686460, topicName=ST段抬高型心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Mon Jun 29 09:38:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326439, encodeId=2e4113264396c, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423097, encodeId=3c73142309eb9, content=<a href='/topic/show?id=936c16863b5' target=_blank style='color:#2F92EE;'>#ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16863, encryptionId=936c16863b5, topicName=ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d33758978, createdName=gdsun, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2066048, encodeId=28142066048e5, content=<a href='/topic/show?id=fec79922910' target=_blank style='color:#2F92EE;'>#非ST段抬高型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99229, encryptionId=fec79922910, topicName=非ST段抬高型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Sep 13 09:38:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826564, encodeId=e639182656416, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Sep 21 16:38:00 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819113, encodeId=669f1819113d3, content=<a href='/topic/show?id=de2d99226e2' target=_blank style='color:#2F92EE;'>#非ST段#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99226, encryptionId=de2d99226e2, topicName=非ST段)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Tue Sep 22 01:38:00 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854612, encodeId=2137185461238, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Aug 14 07:38:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811983, encodeId=e8c48119832b, content=女性非ST段抬高型<a href='/topic/show?id=0cb1510519b' target=_blank style='color:#2F92EE;'>#心梗#</a>患者<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>发生率低于男性,这几乎是必然的。女性的<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的, beContent=null, objectType=article, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51051, encryptionId=0cb1510519b, topicName=心梗), TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Aug 22 09:44:34 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926998, encodeId=ccf3192699811, content=<a href='/topic/show?id=be549922826' target=_blank style='color:#2F92EE;'>#非ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99228, encryptionId=be549922826, topicName=非ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ed3112, createdName=echonoir, createdTime=Wed Mar 25 19:38:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049508, encodeId=e58120495087a, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Wed Jan 15 06:38:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024062, encodeId=c50e20240620a, content=<a href='/topic/show?id=0ee11686460' target=_blank style='color:#2F92EE;'>#ST段抬高型心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16864, encryptionId=0ee11686460, topicName=ST段抬高型心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Mon Jun 29 09:38:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326439, encodeId=2e4113264396c, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423097, encodeId=3c73142309eb9, content=<a href='/topic/show?id=936c16863b5' target=_blank style='color:#2F92EE;'>#ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16863, encryptionId=936c16863b5, topicName=ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d33758978, createdName=gdsun, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2066048, encodeId=28142066048e5, content=<a href='/topic/show?id=fec79922910' target=_blank style='color:#2F92EE;'>#非ST段抬高型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99229, encryptionId=fec79922910, topicName=非ST段抬高型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Sep 13 09:38:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826564, encodeId=e639182656416, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Sep 21 16:38:00 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819113, encodeId=669f1819113d3, content=<a href='/topic/show?id=de2d99226e2' target=_blank style='color:#2F92EE;'>#非ST段#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99226, encryptionId=de2d99226e2, topicName=非ST段)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Tue Sep 22 01:38:00 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854612, encodeId=2137185461238, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Aug 14 07:38:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811983, encodeId=e8c48119832b, content=女性非ST段抬高型<a href='/topic/show?id=0cb1510519b' target=_blank style='color:#2F92EE;'>#心梗#</a>患者<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>发生率低于男性,这几乎是必然的。女性的<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的, beContent=null, objectType=article, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51051, encryptionId=0cb1510519b, topicName=心梗), TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Aug 22 09:44:34 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926998, encodeId=ccf3192699811, content=<a href='/topic/show?id=be549922826' target=_blank style='color:#2F92EE;'>#非ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99228, encryptionId=be549922826, topicName=非ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ed3112, createdName=echonoir, createdTime=Wed Mar 25 19:38:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049508, encodeId=e58120495087a, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Wed Jan 15 06:38:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024062, encodeId=c50e20240620a, content=<a href='/topic/show?id=0ee11686460' target=_blank style='color:#2F92EE;'>#ST段抬高型心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16864, encryptionId=0ee11686460, topicName=ST段抬高型心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Mon Jun 29 09:38:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326439, encodeId=2e4113264396c, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423097, encodeId=3c73142309eb9, content=<a href='/topic/show?id=936c16863b5' target=_blank style='color:#2F92EE;'>#ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16863, encryptionId=936c16863b5, topicName=ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d33758978, createdName=gdsun, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=2066048, encodeId=28142066048e5, content=<a href='/topic/show?id=fec79922910' target=_blank style='color:#2F92EE;'>#非ST段抬高型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99229, encryptionId=fec79922910, topicName=非ST段抬高型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Sep 13 09:38:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826564, encodeId=e639182656416, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Sep 21 16:38:00 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819113, encodeId=669f1819113d3, content=<a href='/topic/show?id=de2d99226e2' target=_blank style='color:#2F92EE;'>#非ST段#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99226, encryptionId=de2d99226e2, topicName=非ST段)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Tue Sep 22 01:38:00 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854612, encodeId=2137185461238, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Aug 14 07:38:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811983, encodeId=e8c48119832b, content=女性非ST段抬高型<a href='/topic/show?id=0cb1510519b' target=_blank style='color:#2F92EE;'>#心梗#</a>患者<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>发生率低于男性,这几乎是必然的。女性的<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的, beContent=null, objectType=article, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51051, encryptionId=0cb1510519b, topicName=心梗), TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Aug 22 09:44:34 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926998, encodeId=ccf3192699811, content=<a href='/topic/show?id=be549922826' target=_blank style='color:#2F92EE;'>#非ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99228, encryptionId=be549922826, topicName=非ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ed3112, createdName=echonoir, createdTime=Wed Mar 25 19:38:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049508, encodeId=e58120495087a, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Wed Jan 15 06:38:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024062, encodeId=c50e20240620a, content=<a href='/topic/show?id=0ee11686460' target=_blank style='color:#2F92EE;'>#ST段抬高型心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16864, encryptionId=0ee11686460, topicName=ST段抬高型心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Mon Jun 29 09:38:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326439, encodeId=2e4113264396c, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423097, encodeId=3c73142309eb9, content=<a href='/topic/show?id=936c16863b5' target=_blank style='color:#2F92EE;'>#ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16863, encryptionId=936c16863b5, topicName=ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d33758978, createdName=gdsun, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=2066048, encodeId=28142066048e5, content=<a href='/topic/show?id=fec79922910' target=_blank style='color:#2F92EE;'>#非ST段抬高型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99229, encryptionId=fec79922910, topicName=非ST段抬高型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Sep 13 09:38:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826564, encodeId=e639182656416, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Sep 21 16:38:00 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819113, encodeId=669f1819113d3, content=<a href='/topic/show?id=de2d99226e2' target=_blank style='color:#2F92EE;'>#非ST段#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99226, encryptionId=de2d99226e2, topicName=非ST段)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Tue Sep 22 01:38:00 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854612, encodeId=2137185461238, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Aug 14 07:38:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811983, encodeId=e8c48119832b, content=女性非ST段抬高型<a href='/topic/show?id=0cb1510519b' target=_blank style='color:#2F92EE;'>#心梗#</a>患者<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>发生率低于男性,这几乎是必然的。女性的<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>保护作用几乎是全方位的,相对而言,女性对疾病的耐受力远远高于男性的, beContent=null, objectType=article, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51051, encryptionId=0cb1510519b, topicName=心梗), TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Aug 22 09:44:34 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926998, encodeId=ccf3192699811, content=<a href='/topic/show?id=be549922826' target=_blank style='color:#2F92EE;'>#非ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99228, encryptionId=be549922826, topicName=非ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ed3112, createdName=echonoir, createdTime=Wed Mar 25 19:38:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049508, encodeId=e58120495087a, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Wed Jan 15 06:38:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024062, encodeId=c50e20240620a, content=<a href='/topic/show?id=0ee11686460' target=_blank style='color:#2F92EE;'>#ST段抬高型心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16864, encryptionId=0ee11686460, topicName=ST段抬高型心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Mon Jun 29 09:38:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326439, encodeId=2e4113264396c, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423097, encodeId=3c73142309eb9, content=<a href='/topic/show?id=936c16863b5' target=_blank style='color:#2F92EE;'>#ST段抬高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16863, encryptionId=936c16863b5, topicName=ST段抬高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d33758978, createdName=gdsun, createdTime=Sat Dec 14 00:38:00 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
    2019-12-14 gdsun

相关资讯

JACC:经导管三尖瓣介入治疗三尖瓣反流预后优于药物治疗

三尖瓣反流会增加患者心衰和死亡的风险,经导管三尖瓣介入治疗(TTVI)是一个很有前景的治疗方法,但其益处尚不清楚。本研究的目的旨在评估TTVI的潜在益处。TriValve数据库收集了2016-2018年来自22个医学中心的472名接受TTVI治疗的患者,对照队列由2个大型接受药物治疗的中度及以上三尖瓣反流患者队列组成,并进行倾向性评分配对,主要终点事件是患者1年死亡率、心衰再住院率或两者的复合事件

JACC:术者经验与经导管二尖瓣修复术预后呈明显相关

经导管二尖瓣修复术(TMVr)是一类复杂的治疗二尖瓣反流的手术,本研究的目的旨在评估术者的操作经验与TMVr预后的相关性。本研究纳入分析了2013-2018年数据库中来自290个医学中心562名术者的14923次TMVr,分析结果发现手术成功率随着术者的操作经验增加而增高(p < 0.001),手术操作时间和并发症发生率降低,这种相关性在调整后的连续变量分析中依旧存在。另外,学习曲线的视觉拐

JACC:脂蛋白(a)浓度与心血管疾病和2型糖尿病发生明显相关

脂蛋白(a)是一个常见的心血管危险因素,且无已知的治疗策略,低水平的LP(a)与2型糖尿病(T2D)的发生相关。本研究的目的旨在探究LP(a)的摩尔浓度或载脂蛋白(a)的大小与心血管的相关性,以及Lp(a)与T2D风险之间是否存在因果关系。本研究是一个包含143087名冰岛人群的病例对照研究,包括17715名冠心病患者和8734名T2D患者,分析结果发现,LP(a)的摩尔浓度与冠心病、外周动脉疾病

盘点:JACC12月第一期研究一览

1. 低外科风险AS患者TAVR依旧是一个更好的选择DOI: 10.1016/j.jacc.2019.09.007http://www.onlinejacc.org/content/74/23/2833对于低外科手术风险的严重主动脉瓣狭窄(AS)患者,经导管主动脉瓣置换术(TAVR)较外科手术的术后1年死亡风险、卒中和再住院风险更低。然而,治疗策略对患者健康状态的影响尚不清楚。本研究的目的旨在

Nat Med:有益肠道细菌可降低心血管疾病风险

最近,比利时鲁汶大学鲁汶药物研究所帕特里斯 · 卡尼团队与荷兰瓦格宁根大学威廉 · 德 · 福斯教授合作,共同发现了一种有益的肠道细菌(Akkermansia muciniphila)能够减少老鼠肥胖和 Ⅱ 型糖尿病的发病率,并且使用巴氏杀菌处理后的 Akkermansia 能够给老鼠带来更有效的防护,降低它们心血管类疾病风险。 在这些发现之后,鲁汶大学的团队开展了一项临床研究,希望将这种细

JACC:专业认证的心脏中心成年先心病心脏移植术后死亡率更低

目前,接受心脏移植的成年先心病(CHD)患者数量急剧上升,CHD患者在心脏移植时外科风险更高,本研究的目的旨在评估CHD中心的手术数量和熟练度对成年CHD患者心脏移植预后的影响。本研究纳入了UNOS数据库中1746名准备接受心脏移植治疗的年龄≥18岁的先心病患者,最终有1006名接受了心脏移植治疗,经过一些基线人口特征的调整分析后,发现成人先天性心脏病协会认可的中心死亡率更低(HR: 0.730;

Baidu
map
Baidu
map
Baidu
map